Read about Epogen, also known as Procrit, in this Bloomberg report. "A drug sold by Amgen Inc. and Johnson & Johnson for people with anemia didn’t reduce heart damage in patients who’d experienced heart attacks and may increase the chances of recurrence or death, a study found. Epogen, approved in 1989 as the first drug for Thousand Oaks, California-based Amgen, is used by patients undergoing kidney dialysis to boost their depleted red blood cells. J&J sells the drug as Procrit, mostly for cancer patients getting chemotherapy."
Saturday, May 21, 2011
Subscribe to:
var sc_project=1725605;
var sc_invisible=0;
var sc_partition=16;
var sc_security="acf71b9a";